Improving our patients’ Quality of life

Adacyte Therapeutics is a pioneering company committed to the development and commercialization of unique and innovative therapeutic solutions for the treatment of complex diseases.

Learn More

Our genuine interest in patients voice inspires our vision to continue globally developing GMA (Granulocyte-Monocyte Apheresis) as an effective and safe treatment option for IBD and other autoimmune diseases. GMA is today a growing and emerging medical technology which offers a therapeutic alternative to the standard treatments.

ANTONI VILLARÓ Founder & CEO
Antoni Villaro image

Our WorkTherapeutic Areas

Autoimmune diseases directly affect more than 27 million people in Europe alone

Our products

Adacolumn Adacolumn
  • GMA offers a therapeutic effect without the debilitating side effects usually associated with immunosuppressive drugs.

Contact UsFor more information

Get in touch